Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Subject-, Investigator-, and Sponsor-blinded, Randomized, Placebo-controlled, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis
Principal Investigator (?)
Study Number
F17164
Summary
This study will investigate the safety and efficacy of VAY736 administered subcutaneously (s.c.) every 4 weeks for 48 weeks. Approximately, 84 subjects will be randomized in a 1:1 ratio on top of local standard of care (SOC), to receive VAY736 or placebo. 
Phase (?)
Phase III
Sponsor (?)
Contact

Kathy Dickie

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0